Janssen Biotech to buy HC2 Holdings subsidiary By: MarketMinute.com Stock News May 02, 2018 at 18:42 PM EDT HC2 Holdings Inc. (NYSE: HCHC) subsidiary BeneVir Biopharma will be acquired by Janssen Biotech. The stock price soared $1.79 to close at $6.96. Related Stocks: Hc2 Holdings Inc